These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 264783)

  • 21. Multiple myeloma resistant to melphalan: treatment with cyclophosphamide, prednisone, and BCNU.
    Kyle RA; Gailani S; Seligman BR; Blom J; McIntyre OR; Pajak TF; Holland JF
    Cancer Treat Rep; 1979 Aug; 63(8):1265-9. PubMed ID: 476704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy for myelomatosis.
    Azam L; Delamore IW
    Br Med J; 1974 Dec; 4(5944):560-4. PubMed ID: 4611585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma.
    Cohen HJ; Silberman HR; Larsen WE; Johnson L; Bartolucci AA; Durant JR
    Blood; 1979 Oct; 54(4):824-36. PubMed ID: 476303
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of metastatic breast cancer with adriamycin-cyclophosphamide induction followed by alternating combination therapy.
    Abeloff MD; Ettinger DS
    Cancer Treat Rep; 1977 Dec; 61(9):1685-9. PubMed ID: 340033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High dose cyclophosphamide, BCNU and VP-16 with autologous blood stem cell support for refractory multiple myeloma.
    Ventura GJ; Barlogie B; Hester JP; Yau JC; LeMaistre CF; Wallerstein RO; Spinolo JA; Dicke KA; Horwitz LH; Alexanian R
    Bone Marrow Transplant; 1990 Apr; 5(4):265-8. PubMed ID: 1970939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitrosourea combinations in lung cancer.
    Livingston RB
    Cancer Treat Rep; 1976 Jun; 60(6):757-760. PubMed ID: 182365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
    Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
    Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy of advanced prostatic cancer with adriamycin, BCNU, and cyclophosphamide.
    Presant CA; Van Amburg A; Klahr C; Metter GE
    Cancer; 1980 Dec; 46(11):2389-92. PubMed ID: 7438014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of the status of the nitrosoureas in other tumors.
    Carter SK
    Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer.
    Jones SE; Durie BG; Salmon SE
    Cancer; 1975 Jul; 36(1):90-7. PubMed ID: 1203853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of anticancer agents by amphotericin B.
    Medoff G; Valeriote F; Dieckman J
    J Natl Cancer Inst; 1981 Jul; 67(1):131-5. PubMed ID: 6942183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination chemotherapy for multiple myeloma with BCNU, cyclophosphamide, vincristine, melphalan, and prednisone (M-2 protocol).
    Case DC; Sonneborn HL; Paul SD; Hayes DM; Dorsk BM; Carroll RJ; Bove L
    Oncology; 1985; 42(3):137-40. PubMed ID: 3858763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
    Durant JR; Loeb V; Dorfman R; Chan YK
    Cancer; 1975 Dec; 36(6):1936-44. PubMed ID: 1106833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial.
    Lloyd RE; Jones SE; Salmon SE; Durie BG; McMahon LJ
    Cancer Treat Rep; 1976 Jan; 60(1):77-83. PubMed ID: 1000520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined chemotherapy for unresectable carcinoma of the lung: a randomized trial.
    Eridani S; Burdick L; Maggio L; Cunietti E; Periti M; Arosio A; Perrone G
    Int J Clin Pharmacol Biopharm; 1978 Oct; 16(10):482-5. PubMed ID: 81190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric cancer: current status of treatment.
    Carter SK; Comis RL
    J Natl Cancer Inst; 1977 Mar; 58(3):567-78. PubMed ID: 402478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas.
    Brajtburg J; Elberg S; Schechtman KB; Medoff G
    Cancer Res; 1990 Jun; 50(11):3274-8. PubMed ID: 2334920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remission maintenance of acute nonlymphoblastic leukemia with BCNU (NSC-409962) and cyclophosphamide (NSC-26271).
    Manaster J; Cowan DH; Curtis JE; Hasselback R; Bergsagel DE
    Cancer Chemother Rep; 1975; 59(3):537-45. PubMed ID: 1060509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
    Frederiksen PL; Joergensen ST; Roesdahl K; Thomsen J; Mouridsen HT
    Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemotherapy of the transplantable acute leukemia L5222 in rats.
    Zeller WJ; Ivankovic S; Schmähl D
    Cancer Res; 1975 May; 35(5):1168-74. PubMed ID: 1120307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.